Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Expert Opinion on Biological Therapy|October 2, 2003
The therapeutic potential of interleukin-6 in treating obesityKristina Wallenius, John-Olov Jansson, Ville WalleniusPPAR Research|November 29, 2013
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker RatKristina Wallenius, Ann Kjellstedt, Pia Thalén, et al.Dose-Response : a Publication of International Hormesis Society|October 8, 2009
Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acidChristine Isaksson, Johan Gabrielsson, Kristina Wallenius, et al.Plos One|December 9, 2014
Pharmacological PPARα activation markedly alters plasma turnover of the amino acids glycine, serine and arginine in the ratAnette Ericsson, Nigel Turner, Göran I Hansson, et al.Biochemical and Biophysical Research Communications|June 11, 2002
Intracerebroventricular interleukin-6 treatment decreases body fat in ratsKristina Wallenius, Ville Wallenius, David Sunter, et al.The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjectsKaj Stenlöf, Ingrid Wernstedt, Ted Fjällman, et al.Diabetes Research and Clinical Practice|August 21, 2024
Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteriaUlrika Andersson-Hall, Emilia Kristiansson, Malin Zander, et al.Endocrinology|February 28, 2004
Reduced exercise endurance in interleukin-6-deficient miceJenny Fäldt, Ingrid Wernstedt, Sharyn M Fitzgerald, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 14, 2003
On the site and mechanism of action of the anti-obesity effects of interleukin-6John-Olov Jansson, Kristina Wallenius, Ingrid Wernstedt, et al.Nature Medicine|January 12, 2002
Interleukin-6-deficient mice develop mature-onset obesityVille Wallenius, Kristina Wallenius, Bo Ahrén, et al.Pageof 3